[5-min read] Q&A with Ismail "Izzy" Ali, Co-Executive Director
[3-min read] Facilitators share how to make sense of psychedelic visuals.
[5-min read] Osmind shares first study of real-world outcomes from Oregon Psilocybin Services.
[6-min read] Q&A with Marissa Feinberg, Social Entrepreneur
[3-min read] Facilitators share how to overcome the fear of your first journey.
[5-min read] NIH awards atai Life Sciences $11.4 million to develop non-hallucinogenic psychedelics.
[5-min read] Q&A with Zeus Tipado, Neuroscientist & Creator
[3-min read] Facilitators weigh in on whether microdosing can heal trauma at the root.
[5-min read] International psychedelic drugmaker files for US Initial Public Offering.
[5-min read] Q&A with Court Wing, Founder & Advocate
[3-min read] Facilitators explain how psychedelics can deepen one's religious faith.
[5-min read] MindMed publishes full results from its Phase 2b trial of LSD for anxiety.
